Assertio Therapeutics Inc logo

ASRT - Assertio Therapeutics Inc News Story

$1.31 -0.0  -2.2%

Last Trade - 21/02/20

Sector
Healthcare
Size
Small Cap
Market Cap £81.5m
Enterprise Value £321.6m
Revenue £164.1m
Position in Universe 4204th / 6408

BRIEF-Assertio Therapeutics Announces Sale Of Gralise For Total Value Of $127.5 Million

Thu 12th December, 2019 1:36pm
Dec 12 (Reuters) - Assertio Therapeutics Inc  ASRT.O :
    * ASSERTIO THERAPEUTICS ANNOUNCES SALE OF GRALISE® FOR TOTAL
TRANSACTION VALUE OF $127.5 MILLION
    * ASSERTIO THERAPEUTICS INC - ALVOGEN WILL PAY ASSERTIO A
TOTAL
VALUE OF $127.5 MILLION
    * ASSERTIO THERAPEUTICS INC - BOTH COS EXPECT MAJORITY OF
ROYALTIES TO BE PAID IN FIRST CALENDAR YEAR
    * ASSERTIO THERAPEUTICS INC -  DEAL VALUE OF $127.5 MILLION
INCLUDES $75 MILLION IN CASH AND BALANCE PAYABLE IN FORM OF A
ROYALTY
    * ASSERTIO THERAPEUTICS - ENTERED INTO AGREEMENT WITH
ALVOGEN
UNDER WHICH ALVOGEN WILL ACQUIRE & ASSUME ALL RESPONSIBILITIES
RELATED TO PRODUCT GRALISE

Source text for Eikon:  ID:nGNX6v8HY4 
Further company coverage:  ASRT.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.